Actxa Invents World’s First Non-Invasive AI-Driven Blood Glucose Evaluation and Monitoring Technology
- Actxa Comms
- Jan 2
- 3 min read
Updated: 2 days ago
FOR IMMEDIATE RELEASE
Singapore, 2 January 2026 — Actxa, a Singapore-based preventive health technology company, today announced significant enhancements to its proprietary BGEM® technology, the world’s first clinically backed, non-invasive, AI-driven blood glucose evaluation and monitoring technology. The advancements strengthen BGEM®’s ability to deliver medical-grade glucose insights through everyday wearables.
One key innovation is BGEM® Glucose Range, a clinically backed, medical-grade technology that estimates blood glucose levels within a numeric range using a quick, one-minute measurement. Developed using data collected through clinical studies, BGEM® Glucose Range offers pain-free and meaningful glucose insights anytime, throughout the day, it provides a cost-effective and convenient approach, making glucose monitoring accessible and sustainable.
BGEM® Glucose Range: Medical-Grade, Non-Invasive Glucose Insight
BGEM® Glucose Range represents a major advancement in non-invasive glucose evaluation. Using data from clinical studies, the technology estimates glucose levels within a dynamic range to enable convenient metabolic monitoring throughout the day.
Regular tracking of glucose trends allows users to:
Observe daily glucose patterns relevant to metabolic health
Identify post-meal glucose spikes
Monitor potential Type II diabetes risk through daily observation of glucose levels
Designed for wearable integration, BGEM® Glucose Range delivers a cost-effective alternative to traditional glucose monitoring methods.
BGEM® Glucose Range combines wearable PPG sensors and AI-driven analysis of digital biomarkers to estimate blood glucose results. [Image source: Actxa]
Everyday Glucose Awareness on the Core Smart Ring
In addition, the Core Smart Ring, Actxa’s first smart ring under the Core range, is integrated with the AI Glucose Scan feature, powered by BGEM® Glucose Status technology, to help users take better control of their metabolic health. The feature enables users to check their glucose status and receive a Normal or Elevated result linked to daily habits.
Developed using clinically collected data, AI Glucose Scan interprets Photoplethysmography (PPG) signals from the Core Smart Ring to provide simple, everyday glucose awareness. Paired with lifestyle and wellness guidance, the Core Smart Ring’s AI Glucose Scan supports healthier decision-making and metabolic awareness.
Driving the Future of Non-Invasive Glucose Monitoring
“Glucose health is becoming a defining challenge for global preventive health, yet most monitoring solutions remain invasive, costly or difficult to sustain,” said Marcus Soo, Chief Executive Officer of Actxa.
“We want to make health insights simple, personal, and actionable. Actxa is empowering individuals and partners to integrate preventative health and glucose awareness into everyday life.”
For further information, please contact:
About Actxa
Actxa, headquartered in Singapore, is a preventive health technology company helping organisations improve population health through science, innovation and deep research. Since 2015, our proprietary AI models and evidence-based methodologies have enabled personalised insights across sleep, activity, stress, recovery, body composition, heart health, and blood glucose indicators. We have developed the world’s first Blood Glucose Evaluation & Monitoring technology.
About BGEM®
BGEM® is the world’s first clinically backed, non-invasive, AI-driven technology for blood glucose evaluation and monitoring. Using Artificial Intelligence (AI) and Machine Learning (ML), the BGEM® algorithm interprets data from Photoplethysmography (PPG) sensors in smart wearables, analyses hundreds of digital biomarkers and transforms them into meaningful glucose insights. This delivers a completely pain-free approach to glucose awareness.
Delivered as a cloud-based SaaS solution, BGEM® enables brands to seamlessly integrate glucose intelligence into their products, empowering millions to take control of their metabolic wellness with ease and confidence.